Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0TU2Z
|
||||
| Former ID |
DNC014031
|
||||
| Drug Name |
2-tosylbenzene-1,4-diol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C13H12O4S
|
||||
| Canonical SMILES |
CC1=CC=C(C=C1)S(=O)(=O)C2=C(C=CC(=C2)O)O
|
||||
| InChI |
1S/C13H12O4S/c1-9-2-5-11(6-3-9)18(16,17)13-8-10(14)4-7-12(13)15/h2-8,14-15H,1H3
|
||||
| InChIKey |
JDVLOEPBUIGUKP-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Beta-ketoacyl-ACP synthase III | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2008 Dec 15;18(24):6402-5. Epub 2008 Oct 25.Synthesis and biological evaluation of novel sulfonyl-naphthalene-1,4-diols as FabH inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.